Genetic Counseling for Breast Cancer

This trial compares two types of genetic counseling for women at higher risk of breast cancer. One group will receive a new form of counseling through educational videos via the MyChart patient portal, known as the Genetic Counseling Patient Preference Intervention. The other group will receive traditional in-person counseling, referred to as Conventional Genetic Counseling. The trial aims to determine if the video-based approach is as effective in helping women understand their risk and make informed decisions. Women who are patients at Ohio State University, use MyChart, and are undergoing routine breast cancer screening may be eligible to participate. This trial could lead to more accessible and personalized genetic counseling options in the future. As an unphased trial, it offers a unique opportunity to contribute to innovative approaches in genetic counseling.

The trial information does not specify whether you need to stop taking your current medications.

Research has shown that genetic counseling is generally safe for patients. This counseling helps individuals understand their breast cancer risk based on genetic factors. Studies have found that tools like educational videos can simplify the process and may reduce stress related to genetic risk.

Regarding safety, no direct evidence indicates harm from these counseling methods. Genetic counseling is not a drug or physical treatment, so it lacks side effects typical of medications. Instead, it focuses on sharing information and supporting personal choices. The Genetic Counseling Patient Preference (GCPP) intervention, which uses videos instead of traditional face-to-face counseling, has not been shown to pose any additional risks.

Researchers are excited about this trial because it explores a new way to deliver genetic counseling for breast cancer patients. Unlike traditional genetic counseling, which involves in-person sessions, the Genetic Counseling Patient Preference (GCPP) intervention uses a series of educational videos to provide pre-genetic test information. This approach could make genetic counseling more accessible and convenient for patients, potentially leading to better understanding and engagement. By comparing this method with conventional counseling, researchers hope to find out if the video-based intervention can effectively meet patients' needs while also being more efficient.

Research has shown that genetic counseling helps people understand their breast cancer risk and receive personalized advice. In this trial, participants will join one of two arms. Arm I involves the Genetic Counseling Patient Preference (GCPP) program, which uses educational videos for counseling. This method aims to match the effectiveness of traditional face-to-face counseling, offered in Arm II as conventional genetic counseling. The goal is to increase genetic knowledge, provide an accurate risk assessment, and reduce breast cancer-related worry. Studies suggest that this video-based approach could make genetic counseling more accessible and convenient. It may also benefit healthcare systems by offering a flexible and patient-friendly option.¹²⁶⁷⁸